Med Tech-related technology assessments and clinical guidelines from NICE in the second half of June 2018

Interventional Procedure Guidance is developed for most of the novel interventional procedures entering the English market. The program focuses solely on the clinical evidence. Recommendations may vary from ‘for research only’ to ‘for use with standard arrangements for clinical governance, consent, and audit.' Recommendations are not binding, although they are followed by providers and commissioners.

In the second half of June NICE published two new Interventional Procedure Guidance:

• Interventional Procedure Guidance Laparoscopic ventral mesh rectopexy for internal rectal prolapse, which covers evidence-based recommendations on laparoscopic ventral mesh rectopexy for internal rectal prolapse in adults. Current evidence on the safety of laparoscopic ventral mesh rectopexy for internal rectal prolapse shows there are well‑recognised, serious but infrequent complications. The evidence on efficacy and safety is limited in quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research
• Interventional Procedure Guidance Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor, which covers evidence-based recommendations on MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor in adults by applying ultrasound to a specific area on 1 side of the brain (thalamus). The evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research

MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety and cost. It does not offer a formal guidance, and it, therefore, does not provide any recommendations.

Two new Medtech Innovation Briefings for PICO negative pressure wound therapy for closed surgical incision wounds (single-use negative pressure wound therapy system) and Ocular Response Analyzer G3 (it can be used to measure corneal hysteresis, a possible risk factor for glaucoma) have been published in the second half of June.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.